Context Therapeutics (CNTX) Other Non-Current Assets (2020 - 2023)

Context Therapeutics has disclosed Other Non-Current Assets across 4 years of filings, most recently posting $24000.0 for Q2 2023.

• Other Non-Current Assets for Q2 2023 came in at $24000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $24000.0 (changed N/A YoY), and the FY2022 annual result was $32750.0, down 35.01% from the prior year.
• Other Non-Current Assets came in at $24000.0 for Q2 2023 at Context Therapeutics, down from $26188.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.8 million in Q3 2021 to a low of $24000.0 in Q1 2022.
• The 4-year median for Other Non-Current Assets is $36031.5 (2022), against an average of $258597.5.
• Across the five-year window, Other Non-Current Assets plunged 97.84% in 2022 and rose 9.12% in 2023, its largest moves.
• Context Therapeutics' Other Non-Current Assets stood at $50367.0 in 2020, then rose by 0.04% to $50389.0 in 2021, then plunged by 35.01% to $32750.0 in 2022, then declined by 26.72% to $24000.0 in 2023.
• The last three Other Non-Current Assets figures came in at $24000.0 (Q2 2023), $26188.0 (Q1 2023), and $32750.0 (Q4 2022), per Business Quant data.